TROX dropped -30.73% to $1.33 from the prior close of $1.92, with nearly the entire decline occurring during Wednesday's regular session after an essentially flat premarket. The driver was the Wall Street Journal report published Tuesday that Tronox creditors have formed two groups and engaged restructuring advisors ahead of negotiations over more than $3B of debt, putting equity holders last in line for any recovery and extending Tuesday's -20.66% slide.
Accenture ( ACN ) is a global professional-services and technology-consulting leader, while Dow ( DOW ) is a cyclical materials-science and chemicals producer — two very different business models and risk profiles. Tickeron AI Verdict: Based on observable trend consistency, earnings momentum, and catalyst strength, Tickeron's AI currently favors ACN over DOW in this comparison.
DOW is a diversified materials and chemicals producer, while OXY is an integrated energy producer, placing the two in different cyclical sectors with distinct drivers. DOW has shown stronger recent price momentum, but its trailing earnings remain negative; OXY is profitable and growing earnings at a faster pace.
DOW has delivered the stronger relative performance in recent quarters, reversing a prior-year loss into a third-quarter profit and outpacing the broader chemicals sector. EMN offers a steadier, specialty-materials business model with a higher dividend yield, but has lagged on year-to-date share-price momentum.
Merger of equals with Olin Corporation is the defining catalyst, expected to close in early 2027, with management targeting roughly $300 million in synergies plus an additional $100 million as legacy chlorine contracts expire. Advanced Materials is the structural growth engine , reporting double-digit volume growth tied to aerospace, power-grid infrastructure, and electric-vehicle (EV) battery applications.
The central target of $11 is the average of the verified analyst price targets that sit above Huntsman's current share price, not the headline consensus of all targets. Huntsman Corporation (HUN) traded near $9.78 at the November 11, 2026 close, meaning the stock would need to rise roughly 12.5% to reach $11.
Huntsman Corporation (HUN) shares climbed about 19.9% over the trailing 30 days, rising from roughly $8.16 to a recent close near $9.78. The advance was driven by stronger third-quarter revenue, improved adjusted EBITDA, and continued progress toward the planned merger of equals with Olin Corporation.
The central target of $1.65 is the rounded arithmetic mean of the most recent analyst price targets, drawn from a set of six analyst targets spanning roughly $1.50 to $2.00. At a latest price near $1.11, reaching $1.65 would require a gain of about 49%, a very large move.
Braskem S.A. (BAK) is expected to report its third-quarter 2026 results around November 11–12, 2026, after the market close. Analyst consensus points to roughly $0.02 in earnings per share (EPS) on about $3.64 billion in revenue, a double-digit top-line gain from the prior-year quarter.
ALB (Albemarle) is the world's largest lithium producer, tied to the energy-storage and electric-vehicle (EV) transition, while MEOH (Methanex) is the world's largest methanol supplier, an industrial chemical feedstock. Both companies posted strong recent quarterly results, but for sharply different reasons: ALB rode recovering lithium prices and cost discipline, while MEOH benefited from geopolitical supply disruptions lifting methanol prices.
Both ALB and DOW swung from year-ago losses to solid profits, but their drivers and trajectories differ sharply. ALB delivered the stronger earnings momentum, with adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) nearly tripling in its most recent quarter on surging lithium pricing.
Albemarle (ALB) delivered a sharp earnings recovery in its latest quarter, driven by higher lithium pricing and disciplined cost control, while Olin (OLN) remains weighed down by weak chemicals fundamentals and elevated leverage. ALB's results signal improving profitability and free cash flow, even as a recent pullback in spot lithium prices pressures near-term sentiment; OLN's story is currently dominated by its pending all-stock merger with Huntsman rather than operating momentum.
Albemarle has posted sharply improving financial results, while Huntsman is navigating weak end-market demand and merger integration uncertainty. Relative performance favors ALB , which has rallied significantly over the past year on recovering lithium pricing, versus a flatter-to-lower trajectory for HUN .
VHI jumped during regular trading on Thursday, climbing from a previous close of $14.29 to $15.30, up +7.07%. The move follows third-quarter 2026 results released after Wednesday's close, showing Valhi swung to net income of $30.2 million ($1.06 per share) from a $22.2 million loss a year earlier, led by a chemicals-segment (TiO2) turnaround, alongside a regular $0.08 quarterly dividend.
Valhi reported net income attributable to stockholders of $30.2 million, or $1.06 per share , for the third quarter of 2026, reversing a loss of $0.78 per share in the year-ago period. The chemicals segment swung to $60.5 million in operating income , compared with a $15.9 million loss a year earlier, on higher titanium dioxide (TiO2) prices and market-share gains.
Green Plains reported third quarter 2026 revenue of $496 million, down 2.5% year over year and below the roughly $520 million consensus estimate. GAAP (Generally Accepted Accounting Principles) earnings per share (EPS) of $1.03 easily exceeded the $0.58 analyst consensus, a 77% beat.
AdvanSix reported third quarter 2026 sales of $431 million, up 15% year over year and above consensus estimates of roughly $426 million. GAAP net loss widened to $7.6 million, or ($0.28) per diluted share, compared with a loss of ($0.10) per share a year earlier.
Revenue of $827 million rose 18% year over year but declined 5% versus the prior quarter. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) reached $101 million , up 36% year over year, with a margin of 12.2%.
Westlake Chemical Partners LP (WLKP) reported third quarter 2026 net income attributable to the partnership of $16.2 million , or $0.46 per limited partner unit , up from $14.7 million, or $0.42 per unit, a year earlier. Total net sales reached $314.5 million , compared with $308.9 million in the third quarter of 2025, driven by higher production and sales volume.
Both DD and DOW beat third-quarter earnings expectations, but their drivers differ: DuPont leaned on organic growth and margin expansion, while Dow leaned on pricing and self-help cost actions. Tickeron AI Verdict: DuPont de Nemours ( DD ) is the favored ticker , reflecting stronger trend consistency, faster organic growth, and cleaner post-separation momentum.